SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (19247)3/5/1999 2:00:00 PM
From: VLAD  Read Replies (1) of 23519
 
Kahuna,

Here are a few questions for you to address:

Astra has invested millions of dollars towards marketing and selling MUSE through their agreements with Vivus. I have had personal confirmation via Astra insiders that they are confident that they can sell MUSE side by side with Viagra. I have also been told that their sales people make MUSE's SAFETY profile the major issue to make MUSE preferable over Viagra.

That being said and the fact that MUSE sales have been respectable in England 3 months post Viagra, do you believe that in light of major near future European market launches that Vius' current share price is justified. (No I am not looking for a $40 Vivus but when compared to its counterparts 2 3/16 is IMO NOT a reasonable value for this company).

If after MUSE is launched throughout Europe and let's say China we see gross annual sales running at about $250M + what IYO would be a fair valuation for Vivus.

Would you agree with the statement that there has been manipulation of Vivus stock whether it be via market makers or other well financed players?

How do you explain the fact that with all of Pfizer's recent advertising (both print adds and TV commercials) new Viagra scripts have continued to be in that same range of 70,000 give or take 5,000?

Has Viagra seen its peak in new prescriptions ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News